GL1X · GenesisL1 explorer

MolNFT v1 · #158384 · protein

Crystal structure of the ivr-165 (H3N2) influenza virus hemagglutinin apo form

6NS9 · Hemagglutinin HA1 chain: “Crystal structure of the ivr-165 (H3N2) influenza virus hemagglutinin apo form”. X-ray diffraction, 3 ligands (NAG, BMA, MAN), 5 pockets (best druggability 0.60). MolNFT v1 #158384 on GenesisL1: 3D…

PDB
6NS9
Type
protein
Length
490 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain
UniProt
L0HR89
Ligands
NAG, BMA, MAN
Pockets
5 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutinin HA1 chainprotein31710% helix, 41% strandL0HR89
BHemagglutinin HA2 chainprotein17352% helix, 15% strandL0HR89

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 12 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • MAN · alpha-D-mannopyranose · sugar

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1500.600.9317empty
2930.370.7617empty
3560.300.7517empty
4500.280.7413empty
5530.240.7217empty

Interfaces

1 interface between chains.

  • A–B · 3050 Ų buried · 46 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 glycan, 6 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6NS9 · Crystal structure of the IVR-165 (H3N2) influenza virus hemagglutinin apo form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.